Phase I, double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects
Latest Information Update: 04 Jan 2024
At a glance
- Drugs KN-060 (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
Most Recent Events
- 04 Jan 2024 New trial record